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LETTERS
Salmonella
Typhimurium
DT104, Italy
To the Editor: The recent article
by Helms et al. described the distribu-
tion of Salmonella enterica serovar
Typhimurium definitive page type 104
(DT104) infections in 29 countries
from 1992 to 2001 (1). Results from
Italy were not presented because rou-
tine phage typing was not performed
before 2001. Since 2002, circulation
of  S. Typhimurium phage types has
been monitored by the laboratory-
based surveillance system Enter-net
Italia, which was coordinated by
Istituto Superiore di Sanità as part of
the European network for the surveil-
lance of foodborne infections (2).
From 2000 to 2004, S. Typhimurium
accounted for ≈40% of all human
Salmonella isolates each year. Since
2002,  ≈20% of the S. Typhimurium
isolates were identified as DT104, and
all had a pentavalent resistance pattern
(resistance to ampicillin, chloram-
phenicol, streptomycin, sulfonamides,
and tetracycline) (3). Although the
results reported by Helms et al. (1)
refer to a different period
(1992–2001), the Italian data are simi-
lar to those from many other countries
in northern and western Europe.
According to the Colindale
scheme for phage typing ([4] and L.R.
Ward, pers. comm.), numerous distin-
guishable DT104 subtypes can be
identified as DT104 A, B, C, H, and
L. Most (90%) S. Typhimurium
DT104 strains isolated during the last
2 years belonged to subtype DT104L.
Emergence of phage subtype
DT104A was identified in June 2004
during an outbreak of salmonellosis in
Rome. This subtype had never been
previously identified in Italy. All
DT104A isolates were susceptible to
the Enter-net panel of antimicrobial
drugs (2), a feature unusual for S.
Typhimurium (5). A total of 63 cases
were confirmed; 61 were from Rome,
and 2 were from a neighboring region.
All isolates had similar pulsed-field
gel electrophoretic profiles when ana-
lyzed with the Salm-gene protocol
(6). Since the outbreak, 1 additional
human isolate of DT104A was identi-
fied from a resident of the same
neighboring region. This isolate was
also susceptible to the panel of antimi-
crobial drugs. A fermented pork sala-
mi was epidemiologically implicated
as the vehicle of infection. No micro-
biologic evidence was found because
no food samples were available when
the outbreak was recognized.
The incidence of DT104 in Italy
has remained stable from 2002
through 2004. However, emergence
of subtype DT104A during a recent
outbreak highlights the need for sub-
typing in identifying communitywide
outbreaks and in monitoring changing
subtype patterns.
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To the Editor: Human entero-
viruses (polioviruses, coxsackievirus
A, coxsackievirus B, echoviruses,
enterovirus 71, and newer recognized
serotypes) belong to the Picorna-
viridae family, Enterovirus genus (1).
They are common viral agents associ-
ated with a diversity of clinical mani-
festations, including respiratory ill-
ness; nonspecific rashes; hand, foot,
and mouth disease; myocarditis; acute
hemorrhagic conjunctivitis; and cen-
tral nervous system (CNS) syndromes
(2). Acute viral infections of the CNS
are the source of a group of globally
distributed diseases, which affect the
population in a sporadic, endemic, or
epidemic way. These infections cause
a number of illnesses, particularly in
children, and may result in serious
sequelae; in severe cases, they can be
fatal (3). Meningitis, encephalitis,
acute flaccid paralysis (poliomyelitis),
mononeuritis, polyneuritis, and Reye
syndrome constitute most of the ill-
nesses (4). Nonpolio enteroviruses are
responsible for >80% of viral menin-
gitis cases in which the etiologic agent
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